stoxline Quote Chart Rank Option Currency Glossary
  
Franklin Genomic Advancements ETF (HELX)
31.7599  0.357 (1.14%)    06-21 11:21
Open: 31.73
High: 31.76
Volume: 2,030
  
Pre. Close: 31.4034
Low: 31.73
Market Cap: 9(M)
Technical analysis
2024-06-21 4:52:51 PM
Short term     
Mid term     
Targets 6-month :  37.78 1-year :  44.13
Resists First :  32.35 Second :  37.78
Pivot price 31.64
Supports First :  31.3 Second :  30.65
MAs MA(5) :  31.64 MA(20) :  31.59
MA(100) :  31.49 MA(250) :  30.07
MACD MACD :  0.1 Signal :  0.1
%K %D K(14,3) :  54.5 D(3) :  55.7
RSI RSI(14): 53.2
52-week High :  32.92 Low :  25.26
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ HELX ] has closed below upper band by 41.5%. Bollinger Bands are 23.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 31.83 - 32.04 32.04 - 32.24
Low: 31.19 - 31.47 31.47 - 31.72
Close: 31.34 - 31.77 31.77 - 32.15
Company Description

Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.

Headline News

Thu, 20 Jun 2024
From AI drones to robots, this fund manager focuses on life-changing technology - MarketWatch

Mon, 22 Apr 2024
5 Best Performing Biotech ETFs in 2024 - Insider Monkey

Mon, 06 Nov 2023
Franklin Templeton Launches Franklin Focused Growth ETF (FFOG) - Yahoo Finance

Thu, 18 May 2023
Revvity (RVTY) Stock Price, News & Analysis - NYSE - MarketBeat

Mon, 05 Oct 2020
Best Mutual Funds: Top Manager Runs 3 New ETFs - Investor's Business Daily

Thu, 04 Jun 2020
The Year of the Active ETF - Wealth Management

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
ETF
Sector:
Financial Services
Industry:
Asset Management
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android